These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2240754)

  • 41. Partial and maximal expiratory flow-volume curves in normal and asthmatic subjects before and after inhalation of metaproterenol.
    Berry RB; Fairshter RD
    Chest; 1985 Nov; 88(5):697-702. PubMed ID: 4053712
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Response to bronchodilator drug administration by a new reservoir aerosol delivery system and a review of other auxiliary delivery systems.
    Tobin MJ; Jenouri G; Danta I; Kim C; Watson H; Sackner MA
    Am Rev Respir Dis; 1982 Oct; 126(4):670-5. PubMed ID: 7125359
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intravenous aminophylline in the treatment of acute bronchospastic exacerbations of chronic obstructive pulmonary disease.
    Seidenfeld JJ; Jones WN; Moss RE; Tremper J
    Ann Emerg Med; 1984 Apr; 13(4):248-52. PubMed ID: 6367554
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A comparison of metaproterenol and theophylline for control of childhood asthma.
    Schuller DE; Oppenheimer PJ
    Clin Pediatr (Phila); 1982 Mar; 21(3):135-42. PubMed ID: 7056011
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Acute effects of aerosolized metaproterenol on breathing pattern of patients with symptomatic bronchial asthma.
    Tobin MJ; Birch S; Jenouri G; Sackner MA
    J Allergy Clin Immunol; 1985 Aug; 76(2 Pt 1):166-72. PubMed ID: 4019949
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of the bronchodilator and cardiac effects of hydroxyphenylorciprenaline and orciprenaline.
    Beardshaw J; MacLean L; Chan-Yeung M
    Chest; 1974 May; 65(5):507-11. PubMed ID: 4596769
    [No Abstract]   [Full Text] [Related]  

  • 47. Metaproterenol in children with chronic asthma.
    Hyde JS; Yamshon D; Isenberg PD; Schur S
    Clin Pharmacol Ther; 1976 Aug; 20(2):207-12. PubMed ID: 780039
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synergism of metaproterenol and theophylline.
    Ziment I; Steen SN
    Chest; 1978 Jun; 73(6 Suppl):1016-7. PubMed ID: 354884
    [No Abstract]   [Full Text] [Related]  

  • 49. Domiciliary metaproterenol nebulization: a bacteriologic survey.
    Popa V; Mays CG; Munkres B
    J Allergy Clin Immunol; 1988 Aug; 82(2):231-6. PubMed ID: 3403862
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Controlled clinical trial of a new dosage form of metaproterenol.
    Beck GJ
    Ann Allergy; 1980 Jan; 44(1):19-22. PubMed ID: 6986110
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dose-response relationship of inhaled metaproterenol sulfate in preschool children with mild asthma.
    Nussbaum E; Eyzaguirre M; Galant SP
    Pediatrics; 1990 Jun; 85(6):1072-5. PubMed ID: 2187175
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Assessment of orciprenaline and isoproterenol infusions in asthmatic patients.
    McEvoy JD; Vall-Spinosa A; Paterson JW
    Am Rev Respir Dis; 1973 Sep; 108(3):490-500. PubMed ID: 4745246
    [No Abstract]   [Full Text] [Related]  

  • 53. Bronchodilator responsiveness in infants with bronchiolitis.
    Tepper RS; Rosenberg D; Eigen H; Reister T
    Pediatr Pulmonol; 1994 Feb; 17(2):81-5. PubMed ID: 8165042
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhaled budesonide in addition to oral corticosteroids to prevent asthma relapse following discharge from the emergency department: a randomized controlled trial.
    Rowe BH; Bota GW; Fabris L; Therrien SA; Milner RA; Jacono J
    JAMA; 1999 Jun; 281(22):2119-26. PubMed ID: 10367823
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical comparison of albuterol, isoetharine, and metaproterenol given by aerosol inhalation.
    Berezuk GP; Schondelmeyer SW; Seidenfeld JJ; Jones WN; Bootman JL
    Clin Pharm; 1983; 2(2):129-34. PubMed ID: 6349905
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Aminophylline increases the toxicity but not the efficacy of an inhaled beta-adrenergic agonist in the treatment of acute exacerbations of asthma.
    Siegel D; Sheppard D; Gelb A; Weinberg PF
    Am Rev Respir Dis; 1985 Aug; 132(2):283-6. PubMed ID: 2862819
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of bronchodilators on the behavior of pulmonary resistance and dynamic compliance as functions of respiratory frequency.
    Cutillo A; Perondi R; Turiel M; Watanabe S; Renzetti AD
    Respiration; 1982; 43(2):88-94. PubMed ID: 7100663
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of a beta2-agonist on airway hyperreactivity in subjects with cervical spinal cord injury.
    DeLuca RV; Grimm DR; Lesser M; Bauman WA; Almenoff PL
    Chest; 1999 Jun; 115(6):1533-8. PubMed ID: 10378545
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of beta-adrenergic agents delivered by nebulizer vs metered dose inhaler with InspirEase in hospitalized asthmatic patients.
    Morley TF; Marozsan E; Zappasodi SJ; Gordon R; Griesback R; Giudice JC
    Chest; 1988 Dec; 94(6):1205-10. PubMed ID: 3191761
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of the acute cardiopulmonary effects of oral albuterol, metaproterenol, and terbutaline in asthmatics.
    Wolfe JD; Yamate M; Biedermann AA; Chu TJ
    JAMA; 1985 Apr; 253(14):2068-72. PubMed ID: 3974097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.